2.08
price up icon6.67%   0.13
after-market Handel nachbörslich: 2.08
loading

Finanzdaten der Entera Bio Ltd-Aktie (ENTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
5.04%
2.062
1.963 2.386 2.33 2.212
Operating Income/Loss
5.04%
-2.062
-1.963 -2.386 -2.33 -2.212
Nonoperating Income/Loss
240.62%
0.045
-0.032 0.036 0.005 0.022
Income/Loss From Continuing Operations Before Tax
1.10%
-2.017
-1.995 -2.35 -2.325 -2.19
Income/Loss From Continuing Operations After Tax
1.10%
-2.017
-1.995 -2.379 -2.325 -2.19
Net Income/Loss
1.10%
-2.017
-1.995 -2.379 -2.325 -2.19
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
18,674%
36.74
0.1957 28.81 28.81 28.81
Diluted Average Shares
18,674%
36.74
0.1957 28.81 28.81 28.81
Basic Earnings Per Share
28.57%
0.05
0.07 0.08 0.08 0.08
Diluted Earnings Per Share
28.57%
0.05
0.07 0.08 0.08 0.08
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$78.04
price up icon 3.24%
$37.88
price up icon 2.07%
$111.24
price up icon 2.35%
$29.32
price up icon 8.31%
$110.03
price up icon 2.51%
biotechnology ONC
$304.30
price up icon 1.77%
Kapitalisierung:     |  Volumen (24h):